- Report
- February 2023
- 220 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Drug Pipelines
- January 2019
- 163 Pages
Global
From €20022EUR$22,000USD£17,165GBP
- Report
- July 2018
- 27 Pages
Global
From €9101EUR$10,000USD£7,802GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2023
- 111 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
Clopidogrel is a cardiovascular drug used to prevent blood clots in people with certain conditions, such as coronary artery disease, peripheral artery disease, and stroke. It works by blocking the action of certain natural substances that can cause blood clots. Clopidogrel is available in both generic and brand-name forms. It is usually taken once a day, with or without food.
Clopidogrel is a widely used drug in the cardiovascular market, with many generic and brand-name versions available. It is often prescribed in combination with other drugs, such as aspirin, to reduce the risk of stroke and heart attack. It is also used to prevent blood clots in people with certain conditions, such as atrial fibrillation.
Some companies in the clopidogrel market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin Pharmaceuticals, and Apotex. Show Less Read more